Lei Wang, Ph.D.

Lei Wang provides oversight of the SRAs working on HPTN studies and serves as statistician and data analyst on prevention protocols.

Dr. Wang received a B.S. in Applied Mathematics and a B.A. in International Trade and Business from Beijing Polytechnic University in Beijing, China in 1997, and an M.S. and a Ph.D. in Applied Statistics from the University of Alabama in 2001. For two years, Dr. Wang was a statistician with the Acute Infection and Early Disease Research Program (AIEDRP), a multi-site network conducting studies to increase the understanding of how HIV infects humans and how the disease progresses to AIDS.

Since joining the HPTN, Dr. Wang has been actively involved in randomization and CRF development for HPTN 046 and 052, monitoring and analysis for HPTN 037 and 052, and closeout and manuscript analysis for HPTN 024. Her experience with a variety of Phase III prevention trials (including perinatal, ART, and IDU studies) has led to her role in providing statistical as well as operational support to the SRAs. She is also involved in methodology research of HIV dynamics, such as characterizing viral load set point.